Osteoradionecrosis treatment in head and neck cancer patients: An overview of systematic reviews

Abstract

AimsEvaluate the existing evidence of osteoradionecrosis (ORN) treatment in adults with head and neck cancer, the methodological quality and the evidence grade within systematic reviews (SRs).MethodsAn extensive systematic literature search of SRs that addressed ORN in head and neck cancer patients was conducted with screening of eligible studies, data extraction, methodological (AMSTAR 2) and evidence quality assessment (GRADE) of the SRs by independent and calibrated authors.ResultsA total of six SRs were enrolled. Based primarily on studies from the 1990s, there is critically low‐ or moderate‐quality evidence that hyperbaric oxygen therapy (HBO) improves ORN healing. From 2005 onward, evidence has been discovered in relation to treatment with pentoxifylline and tocopherol (PENTO). The SRs indicate that the management of ORN with PENTO appears to be promising. The greatest rates of healing are seen in mild and moderate stages of ORN. However, the quality of evidence regarding PENTO, surgery and other treatments remains critically low.ConclusionThere is no standardized protocol to treat ORN. PENTO appears to be the most promising conservative treatment; however, the current level of evidence regarding PENTO is still critically low. More robust clinical studies are needed to establish the best treatment for ORN.

Oral Complications from Oropharyngeal Cancer Therapy

“…For advanced stages, surgical interventions such as sequestrectomy, resection, and reconstructive procedures may be necessary. Hyperbaric oxygen therapy (HBOT) has shown promise in promoting tissue healing and reducing symptom severity, but its effectiveness remains to be further explored [ 81 , 82 ].…”